Investing in the Fight Against Superbugs

Podcast
16 min listen
Namita Nair
August 30, 2024
In this episode

Antimicrobial resistance is getting worse. Set to impact healthcare, agriculture and insurance, it’s a phenomenon worth paying attention to. On this episode, we take a look at whether there’s an investment case for fighting back against the superbugs. 
Listen
Spotify
Apple
YouTube
Transcript
Featuring
Namita Nair
Namita Nair
Vice President, MSCI Research

Subscribe today
to have insights delivered to your inbox.

ESG Now Podcast

The world of ESG explored. A rotating cast of environmental, social, and governance researchers join hosts Mike Disabato and Bentley Kaplan as they discuss the most pressing news of the week. But in an enjoyable way.
Previous episodes

The Retail’s Doctor Will See You Now

You trust a retail store to be convenient. You can walk in and get basically anything you need - be it food, clothes, face wash, batteries...whatever. Retail companies have built their brands on that convenience and affordability factor.
Learn more

Nord Stream 2 and Vaccines for Everyone

As the Russian escalation in Ukraine continues, Germany has decided to suspend certification of the Nord Stream 2 Baltic Sea pipeline that would have doubled Russia's natural gas export capacity to Germany.
See more

The content of this page is for informational purposes only and is intended for institutional professionals with the analytical resources and tools necessary to interpret any performance information. Nothing herein is intended to recommend any product, tool or service. For all references to laws, rules or regulations, please note that the information is provided “as is” and does not constitute legal advice or any binding interpretation. Any approach to comply with regulatory or policy initiatives should be discussed with your own legal counsel and/or the relevant competent authority, as needed.